Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-08-29
2006-08-29
McKenzie, Thomas (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S336000, C514S646000, C546S268100, C546S280400, C564S341000
Reexamination Certificate
active
07098223
ABSTRACT:
According to the invention there is provided a compound the formula I;wherein A, X, B, R1, R2, R3and R4are as defined in the specification.
REFERENCES:
patent: 5811459 (1998-09-01), Breault et al.
patent: 5834468 (1998-11-01), Breault et al.
patent: 5843942 (1998-12-01), Breault et al.
patent: 2001/0047008 (2001-11-01), Baraldi et al.
patent: 0037547 (1981-10-01), None
patent: 0218077 (1987-04-01), None
patent: 0351194 (1990-01-01), None
patent: 0375368 (1990-06-01), None
patent: 0381375 (1990-08-01), None
patent: 0385662 (1990-09-01), None
patent: 0385679 (1990-09-01), None
patent: 0375404 (1994-02-01), None
patent: 0375452 (1994-10-01), None
patent: 0385680 (1995-06-01), None
patent: 0385663 (1995-12-01), None
patent: 0752421 (1997-01-01), None
patent: 9603380 (1996-02-01), None
Wallace, Mark, “Emerging drugs for neuropathic pain”, Expert Opinion Emergin Drugs (2001) 6(2):249-259.
Kennedy et al, “Studies on the Characterization of Prostanoid Receptors”, Advances in Prostaglandin, Thromboxane and Leukotriene Research, 1983, vol. 11, 327-332.
Beauchemin Sophie
Burk Robert M.
Allergan Inc.
Baran Robert J.
Johnson Brent A.
McKenzie Thomas
Robinson Binta
LandOfFree
Arylsulfanyl and heteroarylsulfanyl derivatives for treating... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arylsulfanyl and heteroarylsulfanyl derivatives for treating..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylsulfanyl and heteroarylsulfanyl derivatives for treating... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3644639